MXPA02012897A - Combinations of bisphosphonates, estrogenic agents and optionally estrogens. - Google Patents
Combinations of bisphosphonates, estrogenic agents and optionally estrogens.Info
- Publication number
- MXPA02012897A MXPA02012897A MXPA02012897A MXPA02012897A MXPA02012897A MX PA02012897 A MXPA02012897 A MX PA02012897A MX PA02012897 A MXPA02012897 A MX PA02012897A MX PA02012897 A MXPA02012897 A MX PA02012897A MX PA02012897 A MXPA02012897 A MX PA02012897A
- Authority
- MX
- Mexico
- Prior art keywords
- bisphosphonates
- combinations
- estrogenic agents
- estrogens
- optionally
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21618800P | 2000-07-06 | 2000-07-06 | |
| US21606900P | 2000-07-06 | 2000-07-06 | |
| PCT/US2001/020970 WO2002003976A2 (en) | 2000-07-06 | 2001-06-29 | Combinations of bisphosphonates, estrogenic agents and optionally estrogens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA02012897A true MXPA02012897A (en) | 2003-10-24 |
Family
ID=26910620
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA02012897A MXPA02012897A (en) | 2000-07-06 | 2001-06-29 | Combinations of bisphosphonates, estrogenic agents and optionally estrogens. |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1299093A2 (en) |
| JP (1) | JP2004502730A (en) |
| CN (1) | CN1450913A (en) |
| AU (1) | AU2001273125A1 (en) |
| BR (1) | BR0112364A (en) |
| CA (1) | CA2415052A1 (en) |
| MX (1) | MXPA02012897A (en) |
| WO (1) | WO2002003976A2 (en) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002003989A2 (en) * | 2000-07-06 | 2002-01-17 | Wyeth | Use of substituted indole compounds for treating sphincter incontinence |
| US6376486B1 (en) | 2000-07-06 | 2002-04-23 | American Home Products Corporation | Methods of inhibiting sphincter incontinence |
| US6455568B2 (en) | 2000-07-06 | 2002-09-24 | Wyeth | Combination therapy for inhibiting sphincter incontinence |
| US8668914B2 (en) | 2002-07-24 | 2014-03-11 | Brigham Young University | Use of equol for treating skin diseases |
| CN101965974A (en) | 2002-07-24 | 2011-02-09 | 儿童医院医疗中心 | Compositions and products containing enantiomeric equol, and methods for their making |
| WO2004039327A2 (en) | 2002-10-29 | 2004-05-13 | Colorado State University Research Foundation | Use of equol for treating androgen mediated diseases |
| US8580846B2 (en) | 2002-10-29 | 2013-11-12 | Brigham Young University | Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders |
| PT1790347E (en) | 2002-12-20 | 2015-02-05 | Hoffmann La Roche | High dose ibandronate formulation |
| US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| HUE055321T2 (en) | 2015-10-01 | 2021-11-29 | Olema Pharmaceuticals Inc | Tetrahydro-1h-pyrido[3,4-b]indole anti-estrogenic drugs |
| US10118910B2 (en) | 2015-12-09 | 2018-11-06 | The Board Of Trustees Of The University Of Illinois | Benzothiophene-based selective estrogen receptor downregulators |
| CN109562113A (en) | 2016-05-10 | 2019-04-02 | C4医药公司 | Loop coil degron body for target protein degradation |
| WO2017197055A1 (en) | 2016-05-10 | 2017-11-16 | C4 Therapeutics, Inc. | Heterocyclic degronimers for target protein degradation |
| WO2017197046A1 (en) | 2016-05-10 | 2017-11-16 | C4 Therapeutics, Inc. | C3-carbon linked glutarimide degronimers for target protein degradation |
| CN109789143A (en) | 2016-07-01 | 2019-05-21 | G1治疗公司 | Antiproliferative based on pyrimidine |
| WO2018081168A2 (en) | 2016-10-24 | 2018-05-03 | The Board Of Trustees Of The University Of Illinois | Benzothiophene-based selective mixed estrogen receptor downregulators |
| CN110177554B (en) | 2017-01-06 | 2023-06-02 | G1治疗公司 | Combination therapy for the treatment of cancer |
| CN110461853A (en) | 2017-02-10 | 2019-11-15 | G1治疗公司 | Benzothiophene estrogenic agents |
| CN110913861B (en) | 2017-06-29 | 2024-01-09 | G1治疗公司 | Morphological forms of G1T38 and methods of making the same |
| CN113453679A (en) | 2018-12-20 | 2021-09-28 | C4医药公司 | Targeted protein degradation |
| WO2024030968A1 (en) | 2022-08-03 | 2024-02-08 | Brystol-Myers Squibb Company | Compounds for modulating ret protein |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100620772B1 (en) * | 1998-05-15 | 2006-09-13 | 와이어쓰 | Pharmaceutical composition comprising estrogens and 2-phenyl-1-[4-2-aminoethoxy-benzyl]-indole |
| CN1309637A (en) * | 1998-05-15 | 2001-08-22 | 美国家用产品公司 | Compositions comprising 2-phenyl-indole compounds and estrogen formutations |
| US6465445B1 (en) * | 1998-06-11 | 2002-10-15 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
-
2001
- 2001-06-29 CA CA002415052A patent/CA2415052A1/en not_active Abandoned
- 2001-06-29 CN CN01815091A patent/CN1450913A/en active Pending
- 2001-06-29 AU AU2001273125A patent/AU2001273125A1/en not_active Abandoned
- 2001-06-29 MX MXPA02012897A patent/MXPA02012897A/en unknown
- 2001-06-29 BR BR0112364-5A patent/BR0112364A/en not_active Application Discontinuation
- 2001-06-29 JP JP2002508431A patent/JP2004502730A/en active Pending
- 2001-06-29 EP EP01952365A patent/EP1299093A2/en not_active Withdrawn
- 2001-06-29 WO PCT/US2001/020970 patent/WO2002003976A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2415052A1 (en) | 2002-01-17 |
| BR0112364A (en) | 2003-07-29 |
| CN1450913A (en) | 2003-10-22 |
| AU2001273125A1 (en) | 2002-01-21 |
| JP2004502730A (en) | 2004-01-29 |
| WO2002003976A3 (en) | 2003-01-03 |
| WO2002003976A2 (en) | 2002-01-17 |
| EP1299093A2 (en) | 2003-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA02012897A (en) | Combinations of bisphosphonates, estrogenic agents and optionally estrogens. | |
| MXPA02012891A (en) | Pharmaceutical compositions of estrogenic agents. | |
| AU5208401A (en) | 3-nitrogen-6,7-dioxygen steroids and uses related thereto | |
| MXPA03000183A (en) | Glucocortiocoid-selective antiinflammatory agents. | |
| ZA200204165B (en) | Fulvestrant formulation. | |
| GB2381456B (en) | An anhydrofructose derived antimicrobial agent | |
| GB2375930B (en) | Private wireless WAP system | |
| HUP0400646A3 (en) | Steroid hormone-compositions and processes for their preparation | |
| EP1346724A4 (en) | Remedies for hepatitis c | |
| EP1315094A4 (en) | Agent system | |
| MXPA03001983A (en) | Exemestane as chemopreventing agent. | |
| MXPA03003522A (en) | Diaper. | |
| MXPA02012896A (en) | Combinations of statins, estrogenic agents and optionally estrogens. | |
| EG23262A (en) | Delta -pyrrolines. | |
| MXPA03005568A (en) | Herbicide agent. | |
| HK1055648A1 (en) | Radio. | |
| HK1069770A1 (en) | Remedies for dermatophytosis | |
| IL144455A0 (en) | 16-hydroxyestratrienes as selective estrogens | |
| TW502582U (en) | Transversely-opening-type underpants | |
| ZA200300417B (en) | 16alpha-methyl or ethyl substituted estrogens. | |
| SI1272504T1 (en) | 8beta-hydrocarbyl-substituted estratrienes for use as selective estrogens | |
| EP1291461A4 (en) | Color-recovering agent | |
| ZA200109120B (en) | Use of Arylalkanoylpyridazines. | |
| AU5838601A (en) | 16, 17-carbocyclic condensed steroid compounds having selective estrogenic activity | |
| GB2364635B (en) | Urinal |